Correlation between the use of anastrozole in the window of opportunity and the result of multigene assay & Establishment of patient-derived preclinical models in breast cancer

Not Applicable

Not yet recruiting

• Conditions: Neoplasms

• Registration Number: KCT0009476
• Lead Sponsor: Yonsei University Health System, Severance Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2024-06-24

Recruitment & Eligibility

• Status: Not yet recruiting
• Sex: Female
• Target Recruitment: 105

Inclusion Criteria

1) Those who have voluntarily agreed in writing to participate in this study
2) Aged 19 ~ 70 years old (including women who do not have ovarian function due to ovarian resection, etc.)
3) Stage I-IIIA, hormone-positive, HER2 non-hyper-expressing (negative) primary breast cancer
4) Patients who have consented to undergo surgery and multigene assay
5) Those who understand the contents of the clinical trial, are cooperative with the conduct of the trial, and to be judged to be able to participate until the end of the study

Exclusion Criteria

1) Pregnant or lactating women
2) Patients who have undergone neoadjuvant therapy
3) Prior cancer history within 5 years (skin cancer, papillary thyroid cancer, cervical carcinoma in situ can be included)
4) Others who are judged to be inappropriate by the researcher

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified